BPI
LXRX icon

BFC Planning, Inc.’s Lexicon Pharmaceuticals LXRX Stock Holding History

BFC Planning, Inc.’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.4K Buy
+1,000
New +$1.95K ﹤0.01% 2943

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Sessa Capital
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

BFC Planning, Inc.'s LXRX Position: Q2 2026 in Review

BFC Planning, Inc. opened a new position in Lexicon Pharmaceuticals (LXRX) in Q2 2026: 1,000 shares worth $2.4K. The stake represents ﹤0.01% of the portfolio and ranks #2943 among its holdings.

150 funds tracked by Wall St. Rank hold LXRX as of Q2 2026.

  • BFC Planning, Inc. held 1,000 shares of Lexicon Pharmaceuticals worth $2.4K as of Q2 2026.
  • Lexicon Pharmaceuticals was a new BFC Planning, Inc. position in Q2 2026.
  • Lexicon Pharmaceuticals made up ﹤0.01% of BFC Planning, Inc.'s portfolio in Q2 2026, its #2943 holding.
  • 150 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2026.

Based on BFC Planning, Inc.'s 13F filing for Q2 2026, filed 29 Oct 2026.